Corcept Therapeutics Incorporated logo
Corcept Therapeutics Incorporated CORT
$ 41.35 3.7%

Quarterly report 2025-Q3
added 11-04-2025

report update icon

Corcept Therapeutics Incorporated Total Current Liabilities 2011-2026 | CORT

Annual Total Current Liabilities Corcept Therapeutics Incorporated

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
141 M 105 M 72.5 M 47.5 M 47.5 M 38.8 M 35.6 M 29.6 M 27.4 M 20.9 M 13.6 M 12.7 M 8.36 M 5.03 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
141 M 5.03 M 43.2 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
98.1 M $ 18.31 -1.03 % $ 2.69 B usaUSA
Amgen Amgen
AMGN
23.1 B $ 345.46 1.05 % $ 186 B usaUSA
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
195 M $ 71.47 3.08 % $ 9.56 B usaUSA
Biogen Biogen
BIIB
5.53 B $ 179.45 -0.24 % $ 26.1 B usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Aytu BioScience Aytu BioScience
AYTU
63.1 M $ 2.64 1.54 % $ 16.6 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Adagene Adagene
ADAG
38.2 M $ 3.15 14.55 % $ 177 M chinaChina
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.05 M $ 4.16 3.74 % $ 9.05 B israelIsrael
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
20.2 M $ 1.85 0.54 % $ 166 M israelIsrael
Aptose Biosciences Aptose Biosciences
APTO
4.46 M - -45.71 % $ 1.2 M canadaCanada
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
Celldex Therapeutics Celldex Therapeutics
CLDX
39.5 M $ 24.83 0.93 % $ 1.6 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
54.1 M - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
99.9 M $ 1.41 -0.35 % $ 264 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
15.7 M - 3.16 % $ 1.9 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Aravive Aravive
ARAV
22.1 M - -13.39 % $ 1.45 M usaUSA
Athira Pharma Athira Pharma
ATHA
13.1 M - - $ 269 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
60.7 M $ 1.4 2.19 % $ 357 M britainBritain
AgeX Therapeutics AgeX Therapeutics
AGE
5.91 M - -10.17 % $ 12.2 K usaUSA
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
13.4 M $ 1.72 -1.71 % $ 82 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
72.8 M - -15.15 % $ 60.3 M britainBritain
Brickell Biotech Brickell Biotech
BBI
1.66 M - -5.38 % $ 6.06 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
1.13 B $ 14.24 4.06 % $ 4.4 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.78 M - 1.93 % $ 17.4 M usaUSA
Atreca Atreca
BCEL
16.3 M - -11.76 % $ 5.79 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
160 M $ 6.74 2.43 % $ 1.39 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
58 M - - $ 2.17 B usaUSA